• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿路上皮癌组织增殖和分化标志物的免疫组织化学分析

Immunohistochemical Analysis of Urothelial Carcinoma Tissues for Proliferation and Differentiation Markers.

作者信息

Rose Michael, Gaisa Nadine T

机构信息

Institute of Pathology, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany.

出版信息

Methods Mol Biol. 2018;1655:43-52. doi: 10.1007/978-1-4939-7234-0_4.

DOI:10.1007/978-1-4939-7234-0_4
PMID:28889376
Abstract

Immunohistochemistry is a standard method in histopathology and enables the localized detection of proteins in histological tissue sections. Specific antibodies are bound to cellular antigens, captured by secondary antibodies or polymers, linked to enzymes and visualized by chromogenic substrates. Here, we describe an automated staining technique for larger slide batches as well as a manual protocol for only few slides using a polymer technique. We focus on differentiation markers, measures of cell proliferation, and therapeutic targets in benign and malignant urothelial tissues.

摘要

免疫组织化学是组织病理学中的一种标准方法,可在组织学组织切片中对蛋白质进行定位检测。特异性抗体与细胞抗原结合,由二抗或聚合物捕获,连接到酶上,并通过显色底物进行可视化。在此,我们描述了一种针对较大批量玻片的自动染色技术以及一种使用聚合物技术对少量玻片的手动操作流程。我们关注良性和恶性尿路上皮组织中的分化标志物、细胞增殖指标以及治疗靶点。

相似文献

1
Immunohistochemical Analysis of Urothelial Carcinoma Tissues for Proliferation and Differentiation Markers.尿路上皮癌组织增殖和分化标志物的免疫组织化学分析
Methods Mol Biol. 2018;1655:43-52. doi: 10.1007/978-1-4939-7234-0_4.
2
S100P as a Marker for Urothelial Histogenesis: A Critical Review and Comparison With Novel and Traditional Urothelial Immunohistochemical Markers.S100P作为尿路上皮组织发生的标志物:一项与新型及传统尿路上皮免疫组化标志物的批判性综述与比较
Adv Anat Pathol. 2017 May;24(3):151-160. doi: 10.1097/PAP.0000000000000150.
3
Reduced expression of GATA3 predicts progression in non-muscle invasive urothelial carcinoma of the urinary bladder.GATA3 表达降低预示着膀胱非肌肉浸润性尿路上皮癌的进展。
J Histotechnol. 2020 Mar;43(1):21-28. doi: 10.1080/01478885.2019.1667126. Epub 2019 Sep 24.
4
[Markers of stem cells and their prognostic values for urothelial carcinomas of the urinary tract].[干细胞标志物及其对尿路尿路上皮癌的预后价值]
Urologiia. 2019 Jun(2):40-49.
5
Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma.雄激素受体表达在鉴别低分化尿路上皮癌和前列腺癌中的诊断效用。
J Clin Pathol. 2013 Sep;66(9):779-86. doi: 10.1136/jclinpath-2013-201586. Epub 2013 Jun 17.
6
Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract.免疫组织化学特征可区分尿路上皮来源的癌中的尿路上皮分化与鳞状分化。
Hum Pathol. 2013 Feb;44(2):164-72. doi: 10.1016/j.humpath.2012.05.018. Epub 2012 Sep 17.
7
The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.GATA 结合蛋白 3 在集合管和上尿路尿路上皮癌鉴别诊断中的作用。
Hum Pathol. 2013 Dec;44(12):2651-7. doi: 10.1016/j.humpath.2013.07.006. Epub 2013 Sep 24.
8
Expression of Glypican 3 in low and high grade urothelial carcinomas.磷脂酰肌醇蛋白聚糖3在低级别和高级别尿路上皮癌中的表达。
Diagn Pathol. 2015 Apr 21;10:34. doi: 10.1186/s13000-015-0266-4.
9
Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.胎盘S100(S100P)和GATA3:通过互补DNA微阵列发现的移行上皮和尿路上皮癌标志物。
Am J Surg Pathol. 2007 May;31(5):673-80. doi: 10.1097/01.pas.0000213438.01278.5f.
10
Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract.uroplakin III表达缺失与上尿路尿路上皮癌患者的不良预后相关。
BJU Int. 2006 Jun;97(6):1322-6. doi: 10.1111/j.1464-410X.2006.06158.x.

引用本文的文献

1
Oncolytic virotherapy provides a potent therapy option for squamous bladder cancer.溶瘤病毒疗法为鳞状细胞膀胱癌提供了一种有效的治疗选择。
Sci Rep. 2025 Apr 18;15(1):13443. doi: 10.1038/s41598-025-96419-3.
2
Scoring Systems for Immunohistochemistry in Urothelial Carcinoma.尿路上皮癌免疫组织化学评分系统
Methods Mol Biol. 2023;2684:3-25. doi: 10.1007/978-1-0716-3291-8_1.
3
EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer.表皮生长因子受体(EGFR)活性成瘾促进了基于抗 ERBB 的联合治疗用于鳞状膀胱癌。
Oncogene. 2020 Oct;39(44):6856-6870. doi: 10.1038/s41388-020-01465-y. Epub 2020 Sep 25.